Jing-Yi Zeng

机构：Fujian Medical University, Fujian Provincial Hospital, Southern Medical University · ORCID：0000-0001-9965-1097

发表论文 7 篇 · 总被引 95 次 · h-index 7

代表论文

• Tanshinone IIA attenuates high glucose-induced epithelial-to-mesenchymal transition in HK-2 cells through VDR/Wnt/β-catenin signaling pathway (2021 · Folia Histochemica et Cytobiologica · 被引 22)
• The Effects of Rhubarb for the Treatment of Diabetic Nephropathy in Animals: A Systematic Review and Meta-analysis (2021 · Frontiers in Pharmacology · 被引 18)
• Gut microbiome and metabolome alterations in traditional Chinese medicine damp–heat constitution following treatment with a Chinese patent medicine and lifestyle intervention (2024 · Phytomedicine · 被引 13)
• Targeting the ALS/FTD-associated A-DNA kink with anthracene-based metal complex causes DNA backbone straightening and groove contraction (2021 · Nucleic Acids Research · 被引 13)
• Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy (2023 · Naunyn-Schmiedeberg s Archives of Pharmacology · 被引 12)
• Dimethyl fumarate ameliorates oxidative stress-induced acute kidney injury after traumatic brain injury by activating Keap1-Nrf2/HO-1 signaling pathway (2024 · Heliyon · 被引 8)